Fredag 30 Januari | 20:24:14 Europe / Stockholm
Svenska | English
Investor Relations
Public Relations

Intellego Technologies

Bifogade filer

Prenumeration

Kalender

Est. tid*
2027-02-26 18:00 Bokslutskommuniké 2026
2026-11-27 18:00 Kvartalsrapport 2026-Q3
2026-08-28 18:00 Kvartalsrapport 2026-Q2
2026-05-29 18:00 Kvartalsrapport 2026-Q1
2026-05-27 N/A Årsstämma
2026-02-27 18:00 Bokslutskommuniké 2025
2026-02-23 N/A Extra Bolagsstämma 2025
2025-11-10 - Kvartalsrapport 2025-Q3
2025-08-27 - Kvartalsrapport 2025-Q2
2025-06-05 - X-dag ordinarie utdelning INT 0.00 SEK
2025-06-04 - Årsstämma
2025-05-27 - Kvartalsrapport 2025-Q1
2025-02-28 - Bokslutskommuniké 2024
2024-11-28 - Kvartalsrapport 2024-Q3
2024-08-30 - Kvartalsrapport 2024-Q2
2024-05-27 - X-dag ordinarie utdelning INT 0.00 SEK
2024-05-24 - Årsstämma
2024-04-30 - Kvartalsrapport 2024-Q1
2024-02-21 - Bokslutskommuniké 2023
2023-10-25 - Kvartalsrapport 2023-Q3
2023-09-25 - Extra Bolagsstämma 2023
2023-08-24 - Kvartalsrapport 2023-Q2
2023-06-07 - Kvartalsrapport 2023-Q1
2023-05-12 - X-dag ordinarie utdelning INT 0.00 SEK
2023-05-11 - Årsstämma
2023-03-02 - Bokslutskommuniké 2022
2023-01-30 - Extra Bolagsstämma 2022
2022-11-24 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-08 - Kvartalsrapport 2022-Q1
2022-05-13 - X-dag ordinarie utdelning INT 0.00 SEK
2022-05-12 - Årsstämma
2022-02-24 - Bokslutskommuniké 2021
2021-12-23 - Extra Bolagsstämma 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-19 - Kvartalsrapport 2021-Q2

Beskrivning

LandSverige
ListaFirst North Stockholm
SektorHälsovård
IndustriBioteknik
Intellego Technologies är verksamt inom fotokrom indikatorteknik. Bolaget levererar fotokroma bläck som utformar visuella indikatorer som gör det möjligt att se effekterna av osynligt ultraviolett ljus. Bläcket ändrar färg baserat på exponering för ultraviolett bestrålning eller specifika ämnen. Produkterna används primärt av OEM-tillverkare och används i branschapplikationer globalt. Intellego Technologies grundades 2011 och har sitt huvudkontor i Stockholm.

Intresserad av bolagets nyckeltal?

Analysera bolaget i Börsdata!

Vem äger bolaget?

All ägardata du vill ha finns i Holdings!

Intellego announces cancellation of MoveoMed transaction
2026-01-03 13:15:00

Intellego Technologies [Intellego] announced in October 2025 that its subsidiary Yuvio Technologies [Yuvio] had received an order from MoveoMed GmbH [MoveoMed] valued at EUR 22 million for UV-C disinfection devices to be delivered during 2025. Today MoveoMed informed Intellego, that the order is cancelled.

As a result of the independent forensic investigation that KPMG is conducting in connection with the criminal suspicions directed against the company's former CEO, Intellego has received information that the terms of the order to Yuvio, including payment and delivery terms, were falsified.

“Since the previous CEO was arrested on November 18th, we are turning every stone and all transactions are being reviewed”, says Jacob Laurin, Acting CEO Intellego Technologies AB.

Further information on Intellego’s transactions will follow the independent report from KPMG that will be presented during January, 2026.

Contact


Jacob Laurin, acting CEO and Board Member, Intellego Technologies AB
E-post: jacob.laurin@intellego-technologies.com

About Us

Intellego Technologies develops and manufactures color indicators that show the effect of irradiation with, among other things, invisible ultraviolet light, UV light. Color indicators are used globally in, for example, the disinfection industry, the sunscreen industry, and the manufacturing industry. Intellego's indicators have been developed from the company's patented photochromic ink, which can be adapted to different wavelengths of light and various application areas across a range of different industries. Intellego Technologies was founded in 2011, is headquartered in Stockholm, and is listed on the Nasdaq First North Growth Market.

The company's Certified Adviser on the Nasdaq First North Growth Market Stockholm is Mangold Fondkommission AB.

Intellego's website: https://intellego-technologies.com/en/

Subscribe to Intellego's press releases: https://intellego-technologies.com/sv/pressmeddelanden/

Contact the communications team: communications@intellego-technologies.com

This information is information that Intellego Technologies is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-01-03 13:15 CET.

Attachments

Intellego announces cancellation of MoveoMed transaction

Källa MFN
Enter your email address and you will get a mail for verification you subscription to content on this page and filter


Select the time zone location for site wide time

Europe
London
Oslo
Stockholm
Helsinki

America
New York / Eastern
Chicago / Central
Los Angeles / Western

Ett mail har skickats till den givna adressen. För att logga in, klicka på "Login" i mailet för att verifiera ditt konto

Företag

Pressmeddelanden